Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jack Gauldie, M.D.
McMaster University
Principal Investigator - Mark Levine, M.D.
Ontario Clinical Oncology Group (OCOG)
Principal Investigator - Peter Ellis, M.D.
Juravinski Cancer Centre - Hamilton Health Sciences
Principal Investigator - Richard Tozer, M.D.
Juravinski Cancer Centre - Hamilton Health Sciences
Principal Investigator - Ronan Foley, M.D.
McMaster University
Principal Investigator - Sukhbinder Dhesy-Thind, M.D.
Ontario Clinical Oncology Group; Juravinski Cancer Centre - Hamilton Health Sciences; McMaster University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2005
- Primary completion
- 31 Jul 2009
- Completion
- 31 May 2012
- Last update posted
- 4 Jun 2012
- Registered enrollment
- 5
- Registry id
- NCT00162929
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.